Quality of Life After Stroke

King, Rosemarie B.

doi:10.1161/01.str.27.9.1467

Cited by 474 publications

(432 citation statements)

References 23 publications

Supporting

Mentioning

334

Contrasting

Unclassified

Order By: Relevance

“…Presence of emotional symptoms such as anxiety [30] or Depression adversely affects HRQOL [30,31,32,33,34,35] more than the impairment of physical function [33] because depression negatively influence physical function [34]. Furthermore, stroke leads to substantial deterioration of cognitive function [36] and impaired cognitive function have negative influence on HRQOL [37,38].…”

Section: Psychological Healthmentioning

confidence: 99%

Untitled

2015

APGR

View full text Add to dashboard Cite

Stroke care is aimed at improving physical, functional, psychological and social function and to eventually improve the overall health related quality of life (HRQOL). This paper critically reviewed published papers that reported on stroke survivors' HRQOL and the factors associated with it from the African region.A total of 19 articles met the inclusion criteria for the review and majority of them 12 (63%) are cross-sectional surveys. In Africa, HRQOL deteriorated significantly after stroke. The reported mean score of HRQOL ranges from below 50% to slightly below 70%. Severity of stroke related symptoms, impairment of physical function, and depression were the most important factors determining HRQOL. However, the influence of social function on HRQOL needs further study. The Studies have shown that stroke rehabilitation in Africa leads to significant improvement HRQOL.Finally, this review has highlighted some critical areas of HRQOL in which the intending African researcher needs examined adequately.

show abstract

Section: Psychological Healthmentioning

confidence: 99%

Untitled

2015

APGR

View full text Add to dashboard Cite

show abstract

“…Over half of these patients will develop major or minor depression in the acute care rehabilitation settings 142 . In fact, depression is considered to be the strongest predictor of quality of life in this patient population 143,144 and is associated with reduced rehabilitation treatment efficacy, poor functional recovery, poor social outcomes, increased cognitive impairment and increased mortality 145 . Antidepressants, psychostimulants, counseling and psychotherapy are the most commonly prescribed interventions.…”

Section: Mdd In the Rehabilitation Settingmentioning

confidence: 99%

“…A recent study showed that ten to 15 sessions of rTMS applied on the left DLPFC at a frequency of 10Hz, and an intensity of 110% MT was associated with significant reduction of depressive symptoms by 30% and a remission rate of 10% as compared to placebo intervention. Mild and few adverse effects such as headache were reported [131][132][133][134][135][136][137][138][139][140][141][142][143][144][145][146][147][148][149] . Another advantage of the use of rTMS is the improvement in executive functions by rTMS 150,151 .…”

Section: Mdd In the Rehabilitation Settingmentioning

confidence: 99%

Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting

Brunoni

Teng

Correa³

et al. 2010

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

The use of neuromodulation as a treatment for major depressive disorder (MDD) has recently attracted renewed interest due to development of other non-pharmacological therapies besides electroconvulsive therapy (ECT) such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), deep brain stimulation (DBS), and vagus nerve stimulation (VNS). Method: We convened a working group of researchers to discuss the updates and key challenges of neuromodulation use for the treatment of MDD. results: The state-of-art of neuromodulation techniques was reviewed and discussed in four sections: [1] epidemiology and pathophysiology of MDD; [2] a comprehensive overview of the neuromodulation techniques; [3] using neuromodulation techniques in MDD associated with non-psychiatric conditions; [4] the main challenges of neuromodulation research and alternatives to overcome them. Discussion: ECT is the first-line treatment for severe depression. TMS and tDCS are strategies with a relative benign profile of side effects; however, while TMS effects are comparable to antidepressant drugs for treating MDD; further research is needed to establish the role of tDCS. DBS and VNS are invasive strategies with a possible role in treatment-resistant depression. In summary, MDD is a chronic and incapacitating condition with a high prevalence; therefore clinicians should consider all the treatment options including invasive and non-invasive neuromodulation approaches. Key words: comprehensive review, major depressive disorder, ECT, TMS, clinical guidelines.Estratégias de neuromodulação para o tratamento da depressão maior: desafios e recomendações de uma força-tarefa rEsuMo O uso de técnicas de neuromodulação para o tratamento do transtorno depressivo maior (TDM) tem despertado um renovado interesse nos últimos anos com o desenvolvimento de outras intervenções não-farmacólogicas além da eletroconvulsoterapia (ECT), como a estimulação magnética transcraniana (EMT), a estimulação transcraniana por corrente continua (ETCC), a estimulação cerebral profunda (DBS) e a estimulação de nervo vago (VNS). Método: Nós organizamos um grupo de trabalho com vários pesquisadores para discutir os avanços recentes e os principais desafios para o uso da neuromodulação no tratamento os principais desafios da pesquisa na neuromodulação e alternativas para superá-los. Discussão: ECT é o tratamento de primeira linha para depressão grave. EMT e ETCC são estratégias com um perfil benigno de efeitos adversos; contudo, enquanto os efeitos da EMT são comparáveis ao das drogas antidepressivas para o tratamento da TDM, a eficácia da ETCC ainda precisa ser estabelecida por mais pesquisas clínicas. DBS e VNS são intervenções invasivas com um papel possível para a depressão refratária. Em resumo, TDM é uma condição crônica, incapacitante e de alta prevalência; portanto na prática clínica todas as opções de tratamento possíveis, incluindo as farmacológicas e não-farmacológicas, devem ser consideradas. Palavras-chave: artigo de revisão, tra...

show abstract

“…A depressão nesses pacientes é muito frequente e ela tem sido uma das principais variáveis associadas com a piora da qualidade de vida 30 , dificultando a adesão ao tratamento, comprometendo a percepção geral da saúde, reduzindo os níveis de energia e diminuindo a interação social e a motivação 31 . Vários são os fatores associados ao comprometimento da qualidade de vida, mas a depressão foi considerada um dos mais importantes preditores de baixa qualidade de vida 30,32,33 .…”

Section: Qualidade De Vidaunclassified

Depressão pós-AVC: aspectos psicológicos, neuropsicológicos, eixo HHA, correlato neuroanatômico e tratamento

Terroni

Mattos

Sobreiro³

et al. 2009

Rev. psiquiatr. clín.

View full text Add to dashboard Cite

ResumoContexto: A depressão pós-AVC (DPAVC) possui uma prevalência elevada. Apesar disso, ela é pouco detectada e tratada. Muitos fatores de risco e repercussões negativas na recuperação dos pacientes estão associados à DPAVC. Objetivo: Revisar alguns aspectos da DPAVC como: qualidade de vida, prejuízos cognitivos, eixo HHA, localização do AVC e tratamento. Métodos: Pesquisa dos últimos 10 anos da base de dados MedLine/PubMed usando as palavraschave post-stroke depression, stroke, quality of life, hypercortisolism, cogntitive dysfunction e treatment. Resultados: A prevalência de DPAVC é de 23% a 60%. Há poucos estudos sobre a incidência de DPAVC. A DPAVC está associada a pior prognóstico e evolução, agravo das disfunções cognitivas e redução da qualidade de vida. O hipercortisolismo está associado à DPAVC que ocorre tardiamente ao AVC. AVC em gânglios da base, região frontal esquerda e estruturas do circuito prefrontosubcortical está relacionado à frequência e à gravidade da DPAVC. Conclusões: É necessário melhoria na metodologia dos estudos para maior esclarecimento sobre a fisiopatologia da incidência da DPAVC. Programas objetivando o aumento das taxas de detecção dos pacientes deprimidos se fazem necessários inclusive para a redução dos impactos negativos na recuperação desses pacientes.Terroni LMN, et al. / Rev Psiq Clín. 2009;36(3):100-8 Palavras-chave: depressão pós-AVC, acidente vascular cerebral, qualidade de vida, disfunção cognitiva, hipercortisolismo, tratamento. AbstractBackground: The prevalence of post-stroke depression (PSD) is elevated. Some risk factors and poor outcome have been associated with PSD. The treatment of PSD reduced the negative impact in patients recovery. Appart from these data the PSD has been under diagnosed and under treated. Objective: Review some aspects such as quality of life, cognitive dysfunction, hypercortisolism, stroke localization and treatment of PSD. Methods: MedLine/PubMed database search using the terms post-stroke depression, stroke, quality of life, hypercortisolism, cognitive dysfunction and treatment, published in MedLine in the last 10 years. Results: PSD has a high rate of prevalence, from 23% to 60%. Few incidence rates are investigated. PSD is associated with poor outcome, increase of cognitive dysfunction and reduced quality of life. The hypercortisolism seems to be associated with PSD in the latter period of stroke. Stroke in the left frontal region, basal ganglia and some structures of prefrontosubcortical circuits have been related with

show abstract

Quality of Life After Stroke

Abstract: The identification of depression, social support, and functional status as predictors of quality of life suggests the need to assist stroke survivors in coping and in maintaining and strengthening their support systems.

Cited by 474 publications

References 23 publications

Untitled

Untitled

Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting

Depressão pós-AVC: aspectos psicológicos, neuropsicológicos, eixo HHA, correlato neuroanatômico e tratamento

Contact Info

Product

Resources

About